Ureas with histamine H3-antagonist receptor activity--a new scaffold discovered by lead-hopping from cinnamic acid amides.

A group of tri and tetrasubstituted urea derivatives have been found to be hH(3)-antagonists. The most potent compounds were found in the class of (piperazine-1-yl)-(piperidine-1-yl)-methanones which in addition showed negligible hERG inhibition.

[1]  David A. Price,et al.  The Discovery of Tropane‐derived CCR5 Receptor Antagonists , 2006, Chemical biology & drug design.

[2]  R. Batey,et al.  Carbamoylimidazolium and thiocarbamoylimidazolium salts: novel reagents for the synthesis of ureas, thioureas, carbamates, thiocarbamates and amides , 2005 .

[3]  A. Hancock.  The challenge of drug discovery of a GPCR target: analysis of preclinical pharmacology of histamine H3 antagonists/inverse agonists. , 2006, Biochemical pharmacology.

[4]  J. Kilburn,et al.  Versatile strategies for the solid phase synthesis of small heterocyclic scaffolds: [1,3,4]-thiadiazoles and [1,3,4]-oxadiazoles , 2005 .

[5]  P. Leeson,et al.  Substituted pyrazoles as novel selective ligands for the human dopamine D4 receptor. , 1998, Bioorganic & medicinal chemistry.

[6]  D. Heimbrook,et al.  Potent N-(1,3-thiazol-2-yl)pyridin-2-amine vascular endothelial growth factor receptor tyrosine kinase inhibitors with excellent pharmacokinetics and low affinity for the hERG ion channel. , 2004, Journal of medicinal chemistry.

[7]  S. M. Knudsen,et al.  1-alkyl-4-acylpiperazines as a new class of imidazole-free histamine H(3) receptor antagonists. , 2004, Journal of medicinal chemistry.

[8]  Xiaohong Zhu,et al.  Identification of a novel, orally bioavailable histamine H(3) receptor antagonist based on the 4-benzyl-(1H-imidazol-4-yl) template. , 2002, Bioorganic & medicinal chemistry letters.

[9]  Rob Leurs,et al.  Keynote review: histamine H3 receptor antagonists reach out for the clinic. , 2005, Drug discovery today.

[10]  R. Young,et al.  Optimization of a tertiary alcohol series of phosphodiesterase-4 (PDE4) inhibitors: structure-activity relationship related to PDE4 inhibition and human ether-a-go-go related gene potassium channel binding affinity. , 2003, Journal of medicinal chemistry.

[11]  H. H. Refsgaard,et al.  Cinnamic amides of (S)-2-(aminomethyl)pyrrolidines are potent H3 antagonists. , 2004, Bioorganic & medicinal chemistry.

[12]  R. Leurs,et al.  The histamine H3 receptor: from gene cloning to H3 receptor drugs , 2005, Nature Reviews Drug Discovery.